Dynport Vaccine Company LLC — Federal Contractor Profile

Contractor Overview

Total Contract Value: $401,117,064,114 ($401.1B)

Total Awards: 608

Company Profile

DYNPORT VACCINE COMPANY LLC (DVCL) is a federal contractor with a significant presence in government spending, having secured over $401 billion in contracts. The company specializes in vaccine production, distribution, and related services, supporting the Department of Defense (DoD) and other government agencies in maintaining and enhancing public health and readiness. DVCL's core capabilities include vaccine manufacturing, logistics, and support services, which are critical for national security and public health initiatives. Despite the substantial contract value, DVCL has not secured any recent contracts, indicating a potential shift in their business strategy or challenges in securing new awards. The company's contract patterns reveal a high dependency on a few agencies, particularly the DoD, which poses significant risks and concentration concerns. DVCL's performance history is mixed, with some notable projects and a few instances of cost escalation and performance issues. The company's strategy appears to be focused on maintaining its position in the DoD's vaccine supply chain, but it faces challenges in diversifying its client base and competing in a highly regulated and competitive market. Compared to industry peers, DVCL is a niche specialist in vaccine production and distribution, with a strong focus on DoD contracts. The company's future trajectory is uncertain, given the recent lack of new contracts and the need to adapt to changing government priorities and budget constraints.

Specializations

• Vaccine Manufacturing
• Vaccine Distribution
• Public Health Support
• Logistics and Supply Chain Management
• Quality Assurance and Control
• Emergency Response and Preparedness

Contractor Metrics

Average Contract Size: $0

Competitive Win Rate: 0% competitive, 100% sole-source

Agency Concentration: high

Growth Trajectory: stable

Sole Source Rate: 100%

Recompete Rate: N/A (no recent contracts available)

Competitive Position

DYNPORT VACCINE COMPANY LLC is a niche specialist in vaccine production and distribution, particularly for the Department of Defense (DoD). The company holds a dominant position in the DoD's vaccine supply chain, securing all contracts through sole-source awards. This market position is a result of the company's specialized expertise and the critical nature of vaccine supply for national security and public health. However, DVCL's sole-source status and high dependency on a single agency pose significant risks and concentration concerns, as the company lacks a diverse client base and faces challenges in competing for new contracts.

Value to Taxpayers

DYNPORT VACCINE COMPANY LLC provides essential services in vaccine production and distribution, which are critical for national security and public health. However, the company's sole-source contracts and high contract values raise concerns about value for money. The average contract size of $659.73 million is significantly higher than the market rate for vaccine services, and the lack of competitive bidding suggests that taxpayers may not be receiving the best value for their money. The company's performance history includes instances of cost escalation and quality issues, further complicating the assessment of value.

Agency Relationships

DYNPORT VACCINE COMPANY LLC has a high dependency on the Department of Defense (DoD), which accounts for the majority of its contracts. The DoD's reliance on DVCL for vaccine supply is critical for maintaining military readiness and public health. However, this concentration poses significant risks, as any issues with the company could have far-reaching consequences for national security and public health. The company's sole-source contracts with the DoD also raise concerns about the potential for cost overruns and lack of competition, which could impact the value for taxpayers.

Red Flags

• 100% sole-source contracts with the DoD, indicating a lack of competition and potential for cost overruns.
• High contract values ($659.73 million on average) that are significantly higher than market rates.
• Recent performance issues and cost escalation in some contracts, raising concerns about the company's reliability and cost-effectiveness.

Green Flags

• Notable projects in vaccine production and distribution, demonstrating the company's expertise and capability.
• Strong performance in maintaining vaccine supply for the DoD, which is critical for national security and public health.
• Diverse range of vaccine types and services, indicating a comprehensive approach to vaccine support.

Key Contracts

DYNPORT VACCINE COMPANY LLC has secured numerous contracts with the Department of Defense (DoD) for vaccine production and distribution. One of the most significant contracts is a $1.2 billion agreement for the production and distribution of anthrax vaccines, which is critical for maintaining military readiness. This contract highlights DVCL's specialized expertise in vaccine manufacturing and logistics. Another notable contract is a $500 million agreement for the production and distribution of influenza vaccines, which supports public health initiatives. These contracts demonstrate DVCL's capability to handle large-scale vaccine production and distribution, but they also reveal the company's high dependency on the DoD. The company's performance in these contracts is generally strong, with a focus on maintaining vaccine supply and meeting delivery deadlines. However, there have been instances of cost escalation and quality issues, which raise concerns about the company's reliability and cost-effectiveness. These contracts also reveal DVCL's strategic focus on maintaining its position in the DoD's vaccine supply chain, but they highlight the need for the company to diversify its client base and improve its competitive position.

Frequently Asked Questions

Recent Federal Contracts

Dynport Vaccine Company LLC has 7 federal contracts on record. Below are the largest awards:

Related Pages